Sakhanda Wire
NVDA $153.77 -1.52% MSFT $506.06 -2.30% GOOGL $280.21 -1.24% META $622.96 -0.55% AMZN $257.51 -0.09%
← Back to the news

Breast cancer AI tools deliver fewer benefits than radiologists expected

A survey published in Clinical Imaging found that about half of 215 members of the Society of Breast Imaging already use FDA-approved artificial intelligence tools for breast cancer detection. Another 11 percent said they plan to adopt them. Lead author Joud Almogati of UC San Diego Health said that only a small number of respondents consider AI a factor that determines their decisions.

The reported benefits were below expectations. Thirty-five percent of respondents said the tools reduced recall rates, compared with 59 percent who had expected that result. Nine percent reported fewer unnecessary biopsies, while 36 percent had anticipated such a reduction. Less burnout was reported by 29 percent, against an expectation of 56 percent. Most respondents described AI primarily as a second opinion.

The survey identified cost and insufficient institutional support as the main obstacles to wider use. The findings come amid earlier predictions that radiologists would soon lose their jobs to AI. Nvidia CEO Jensen Huang has described such forecasts about AI-driven job losses as a “God complex” among their proponents.

Written by Sakhanda Wire AI from reporting by The Decoder. Facts, quotes and full context are in the original article below.

Originally published by The Decoder on

Read the original on The Decoder ↗

The reporting and the image belong to The Decoder and are credited and linked above; the text on this page is Sakhanda Wire's own summary.

← Back to the news

More stories

All the latest news